Kansas City Life Insurance Co (OTCMKTS:KCLI) Declares Quarterly Dividend of $0.27

Share on StockTwits

Kansas City Life Insurance Co (OTCMKTS:KCLI) announced a quarterly dividend on Monday, July 22nd, Zacks reports. Investors of record on Thursday, August 1st will be paid a dividend of 0.27 per share by the financial services provider on Wednesday, August 7th. This represents a $1.08 annualized dividend and a yield of 3.32%. The ex-dividend date of this dividend is Wednesday, July 31st.

Shares of KCLI stock opened at $32.55 on Tuesday. Kansas City Life Insurance has a 12-month low of $32.01 and a 12-month high of $42.99. The stock has a 50 day moving average of $32.75. The stock has a market capitalization of $314.12 million, a PE ratio of 16.17 and a beta of 0.33.

Kansas City Life Insurance (OTCMKTS:KCLI) last issued its earnings results on Thursday, August 1st. The financial services provider reported $0.54 earnings per share (EPS) for the quarter. The company had revenue of $129.88 million for the quarter. Kansas City Life Insurance had a net margin of 3.89% and a return on equity of 2.75%.

Separately, ValuEngine cut shares of Kansas City Life Insurance from a “hold” rating to a “sell” rating in a research note on Friday, June 28th.

About Kansas City Life Insurance

Kansas City Life Insurance Company, together with its subsidiaries, operates as a life insurance company in the United States. It operates through three segments: Individual Insurance, Group Insurance, and Old American. The company offers term, return of premium, universal, indexed universal, variable universal, and whole life insurance products, as well as annuities.

Featured Article: Is a Roth IRA right for you?

Dividend History for Kansas City Life Insurance (OTCMKTS:KCLI)

Receive News & Ratings for Kansas City Life Insurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kansas City Life Insurance and related companies with MarketBeat.com's FREE daily email newsletter.